1. Progress towards measles elimination--African Region, 2017-2021/Progres realises en vue d'eliminer la rougeole--Region africaine, 2017-2021
- Author
-
Masresha, Balcha G., Hatcher, Cynthia, Lebo, Emmaculate, Tanifum, Patricia, Bwaka, Ado M., Minta, Anna A., Antoni, Sebastien, Grant, Gavin B., Perry, Robert T., and O'Connor, Patrick
- Subjects
Vaccination ,Epidemics -- Côte d'Ivoire -- Nigeria -- Botswana -- Gabon -- Cabo Verde -- Sao Tome and Principe -- Rwanda -- Congo (Kinshasa) -- Seychelles -- Burkina Faso ,Measles ,Vaccines ,Coronaviruses ,Government ,Health ,United Nations. Children's Fund - Abstract
Worldwide, measles remains a major cause of disease and death; the highest incidence is in the WHO African Region (AFR). In 2011, the 46 Member States in the AFR established the goal of regional elimination of measles by 2020; this report describes progress during 2017-2021. Regional coverage with a first dose of measles-containing vaccine (MCV) decreased from 70% in 2017 to 68% in 2021, and the number of countries with [greater than or equal to] 95% coverage decreased from 6 (13%) to 2 (4%). The number of countries that provided a second MCV dose increased from 27 (57%) to 38 (81%), and coverage with a second-dose increased from 25% to 41%. Approximately 341 million people were vaccinated during supplementary immunization activities (SIAs), and an estimated 4.5 million deaths were averted by vaccination. The number of countries that met measles surveillance performance indicators decreased, however, from 26 (62%) to 9 (22%). Measles incidence increased from 69.2 per 1 million population in 2017 to 81.9 in 2021. The number of estimated annual measles cases and deaths increased by 22% and 8%, respectively. By December 2021, no country had received verification of measles elimination. To achieve a renewed regional goal of measles elimination in at least 80% of countries by 2030, intensified work is necessary to recover and surpass levels of surveillance performance and coverage with 2 MCV doses that were achieved before the coronavirus disease 2019 (COVID-19) pandemic. La rougeole demeure une cause majeure de maladie et de deces dans le monde entier, et la Region ou l'incidence est la plus elevee est la Region africaine de l'OMS. En 2011, les 46 Etats Membres de la Region africaine s'etaient fixe l'objectif d'eliminer la rougeole a l'horizon 2020. Le present rapport decrit les progres realises sur la periode 2017-2021. La couverture regionale par la premiere dose de vaccin a valence rougeole (MCV) a baisse, passant de 70% en 2017 a 68% en 2021, de meme que le nombre de pays assurant une couverture [greater than or equal to] 95% par la premiere dose, qui est passe 6 (13%) a 2 (4%). Le nombre de pays qui ont administre la deuxieme dose de MCV et la couverture par la deuxieme dose ont augmente, passant de 27 (57%) a 38 (81%) et de 25% a 41%, respectivement. Environ 341 millions de personnes ont ete vaccinees au cours des activites de vaccination supplementaire (AVS) et on estime que 4,5 millions de deces ont ete evites grace a la vaccination. Le nombre de pays qui ont satisfait aux indicateurs de performance de la surveillance de la rougeole a toutefois chute, passant de 26 (62%) a 9 (22%), tandis que l'incidence de la rougeole a augmente, passant de 69,2 cas par million d'habitants en 2017 a 81,9 en 2021; le nombre annuel estime de cas de rougeole et de deces associes a progresse de 22% et de 8%, respectivement. En decembre 2021, aucun pays n'avait obtenu la verification de l'elimination de la rougeole. Pour atteindre l'objectif regional renouvele consistant a eliminer la rougeole dans au moins 80% des pays de la Region d'ici a 2030, il est necessaire de redoubler d'efforts pour retrouver et depasser les niveaux de performance de la surveillance et de couverture par 2 doses de MCV qui avaient ete atteints avant la pandemie de maladie a coronavirus 2019 (COVID-19)., Introduction Measles remains a major cause of disease and death worldwide, and the highest numbers of cases and deaths occur in AFR. (1) In 2011, the 46 Member States (2) [...]
- Published
- 2023